Clinical Trial Update: Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal methylprednisolone for acute relapses in Relapsing-Remitting Multiple Sclerosis. The study is currently enrolling b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Universidad Nacional Autonoma de Mexico | Conditions: Multiple Sclerosis Relapsing Remitting, Treatment | Phase 2 | Status: ENROLLING_BY_INVITATION